Buckland Andrew J 4
4 · PURE BIOSCIENCE · Filed May 10, 2010
Insider Transaction Report
Form 4
PURE BIOSCIENCEPURE
Buckland Andrew J
Chief Financial Officer
Transactions
- Award
Stock Option
2010-05-06+80,000→ 80,000 totalExercise: $3.09From: 2011-05-06Exp: 2020-05-06→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]10 year term, vesting in fourths over 4 years. Granted pursuant to PURE Bioscience 2007 Equity Compensation Plan.